BUPIVACAINE INJECTION BP DIN 02539772
Health Canada record
| Active ingredient(s) | BUPIVACAINE HYDROCHLORIDE 2.5 MG |
|---|---|
| Dosage form | Solution |
| Route | Epidural; Block/Infiltration |
| Schedule | ETHICAL |
| Class | Human |
| ATC | N01BB01 BUPIVACAINE |
| Original market date | |
| Current status date | 21-Jul-2023 |
| Source | Health Canada DPD |
Establishment licence of the holder
Eugia Pharma Inc. — licence 3-002768, currently licensed, last inspection rating C (2026-02-04).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing BUPIVACAINE HYDROCHLORIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02470616 | BUPIVACAINE HEAVY INJECTION BP | AURO PHARMA INC | Solution | BUPIVACAINE HYDROCHLORIDE 15 MG | Approved |
| 02535351 | BUPIVACAINE HEAVY INJECTION BP | EUGIA PHARMA INC. | Solution | BUPIVACAINE HYDROCHLORIDE 15 MG | Approved |
| 02536714 | BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP | FORMATIVE PHARMA INC. | Solution | BUPIVACAINE HYDROCHLORIDE 7.5 MG | Marketed |
| 02460645 | BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP | STERIMAX INC | Solution | BUPIVACAINE HYDROCHLORIDE 7.5 MG | Marketed |
| 02512424 | BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP | OMEGA LABORATORIES LIMITED | Solution | BUPIVACAINE HYDROCHLORIDE 7.5 MG | Marketed |
| 02569094 | BUPIVACAINE HYDROCHLORIDE INJECTION USP | HIKMA CANADA LIMITED | Solution | BUPIVACAINE HYDROCHLORIDE 2.5 MG | Approved |
| 02568519 | BUPIVACAINE HYDROCHLORIDE INJECTION USP | FORMATIVE PHARMA INC. | Solution | BUPIVACAINE HYDROCHLORIDE 5 MG | Approved |
| 02568500 | BUPIVACAINE HYDROCHLORIDE INJECTION USP | FORMATIVE PHARMA INC. | Solution | BUPIVACAINE HYDROCHLORIDE 2.5 MG | Approved |
| 02569108 | BUPIVACAINE HYDROCHLORIDE INJECTION USP | HIKMA CANADA LIMITED | Solution | BUPIVACAINE HYDROCHLORIDE 5 MG | Approved |
| 02507625 | BUPIVACAINE HYDROCHLORIDE INJECTION USP | OMEGA LABORATORIES LIMITED | Solution | BUPIVACAINE HYDROCHLORIDE 7.5 MG | Approved |
| 02488930 | BUPIVACAINE HYDROCHLORIDE INJECTION, USP | BAXTER CORPORATION | Solution | BUPIVACAINE HYDROCHLORIDE 7.5 MG | Marketed |
| 02504960 | BUPIVACAINE HYDROCHLORIDE INJECTION, USP | STERIMAX INC | Solution | BUPIVACAINE HYDROCHLORIDE 5 MG | Approved |
| 02504952 | BUPIVACAINE HYDROCHLORIDE INJECTION, USP | STERIMAX INC | Solution | BUPIVACAINE HYDROCHLORIDE 2.5 MG | Approved |
| 02488922 | BUPIVACAINE HYDROCHLORIDE INJECTION, USP | BAXTER CORPORATION | Solution | BUPIVACAINE HYDROCHLORIDE 5 MG | Approved |
| 02488914 | BUPIVACAINE HYDROCHLORIDE INJECTION, USP | BAXTER CORPORATION | Solution | BUPIVACAINE HYDROCHLORIDE 2.5 MG | Approved |
| 02443694 | BUPIVACAINE INJECTION BP | STERIMAX INC | Solution | BUPIVACAINE HYDROCHLORIDE 5 MG | Marketed |
| 02457547 | BUPIVACAINE INJECTION BP | AURO PHARMA INC | Solution | BUPIVACAINE HYDROCHLORIDE 2.5 MG | Approved |
| 02457555 | BUPIVACAINE INJECTION BP | AURO PHARMA INC | Solution | BUPIVACAINE HYDROCHLORIDE 5 MG | Approved |
| 02539780 | BUPIVACAINE INJECTION BP | EUGIA PHARMA INC. | Solution | BUPIVACAINE HYDROCHLORIDE 5 MG | Approved |
| 02443686 | BUPIVACAINE INJECTION BP | STERIMAX INC | Solution | BUPIVACAINE HYDROCHLORIDE 2.5 MG | Marketed |
| 02305909 | MARCAINE | PFIZER CANADA ULC | Solution | BUPIVACAINE HYDROCHLORIDE 250 MG | Marketed |
| 02241917 | MARCAINE | PFIZER CANADA ULC | Solution | BUPIVACAINE HYDROCHLORIDE 150 MG | Marketed |
| 02474247 | MARCAINE | SEPTODONT INC | Solution | BUPIVACAINE HYDROCHLORIDE 5 MG; EPINEPHRINE BITARTRATE 0.0091 MG | Marketed |
| 02241916 | MARCAINE E | PFIZER CANADA ULC | Solution | BUPIVACAINE HYDROCHLORIDE 100 MG; EPINEPHRINE BITARTRATE 0.182 MG | Marketed |
| 02241915 | MARCAINE E | PFIZER CANADA ULC | Solution | BUPIVACAINE HYDROCHLORIDE 50 MG; EPINEPHRINE BITARTRATE 0.182 MG | Marketed |
| 01976168 | SENSORCAINE | ASPEN PHARMACARE CANADA INC. | Solution | BUPIVACAINE HYDROCHLORIDE 5 MG | Marketed |
| 01976141 | SENSORCAINE | ASPEN PHARMACARE CANADA INC. | Solution | BUPIVACAINE HYDROCHLORIDE 2.5 MG | Marketed |
| 01976206 | SENSORCAINE WITH EPINEPHRINE | ASPEN PHARMACARE CANADA INC. | Solution | BUPIVACAINE HYDROCHLORIDE 5 MG; EPINEPHRINE (EPINEPHRINE BITARTRATE) 5 MCG | Marketed |
| 01976184 | SENSORCAINE WITH EPINEPHRINE | ASPEN PHARMACARE CANADA INC. | Solution | BUPIVACAINE HYDROCHLORIDE 2.5 MG; EPINEPHRINE (EPINEPHRINE BITARTRATE) 5 MCG | Marketed |
| 02381850 | BUPIVACAINE HCL 0.5% AND EPINEPHRINE 1:200,000 INJECTION | NOVOCOL PHARMACEUTICAL OF CANADA INC | Solution | BUPIVACAINE HYDROCHLORIDE 5 MG; EPINEPHRINE BITARTRATE 0.0091 MG | Dormant |
| 02430908 | BUPIVACAINE HYDROCHLORIDE INJECTION USP | MYLAN PHARMACEUTICALS ULC | Solution | BUPIVACAINE HYDROCHLORIDE 7.5 MG | Cancelled Pre Market |
| 02430886 | BUPIVACAINE HYDROCHLORIDE INJECTION USP | MYLAN PHARMACEUTICALS ULC | Solution | BUPIVACAINE HYDROCHLORIDE 2.5 MG | Cancelled Pre Market |
| 02430894 | BUPIVACAINE HYDROCHLORIDE INJECTION USP | MYLAN PHARMACEUTICALS ULC | Solution | BUPIVACAINE HYDROCHLORIDE 5 MG | Cancelled Pre Market |
| 02430916 | BUPIVACAINE HYDROCHLORIDE INJECTION USP | MYLAN PHARMACEUTICALS ULC | Solution | BUPIVACAINE HYDROCHLORIDE 5 MG | Cancelled Pre Market |
| 02430924 | BUPIVACAINE HYDROCHLORIDE INJECTION USP | MYLAN PHARMACEUTICALS ULC | Solution | BUPIVACAINE HYDROCHLORIDE 2.5 MG | Cancelled Pre Market |
| 02165414 | BUPIVACAINE HYDROCHLORIDE INJECTION USP .25% | HOSPIRA HEALTHCARE ULC | Solution | BUPIVACAINE HYDROCHLORIDE 2.5 MG | Cancelled Post Market |
| 02165422 | BUPIVACAINE HYDROCHLORIDE INJECTION USP .50% | HOSPIRA HEALTHCARE ULC | Solution | BUPIVACAINE HYDROCHLORIDE 5 MG | Cancelled Post Market |
| 02165430 | BUPIVACAINE HYDROCHLORIDE INJECTION USP .75% | HOSPIRA HEALTHCARE ULC | Solution | BUPIVACAINE HYDROCHLORIDE 7.5 MG | Cancelled Post Market |
| 02504979 | BUPIVACAINE HYDROCHLORIDE INJECTION, USP | STERIMAX INC | Solution | BUPIVACAINE HYDROCHLORIDE 7.5 MG | Dormant |
| 02432285 | JAMP-BUPIVACAINE | JAMP PHARMA CORPORATION | Solution | BUPIVACAINE HYDROCHLORIDE 5 MG | Cancelled Pre Market |
| 02432277 | JAMP-BUPIVACAINE | JAMP PHARMA CORPORATION | Solution | BUPIVACAINE HYDROCHLORIDE 5 MG | Cancelled Pre Market |
| 02432269 | JAMP-BUPIVACAINE | JAMP PHARMA CORPORATION | Solution | BUPIVACAINE HYDROCHLORIDE 2.5 MG | Cancelled Pre Market |
| 02432250 | JAMP-BUPIVACAINE | JAMP PHARMA CORPORATION | Solution | BUPIVACAINE HYDROCHLORIDE 2.5 MG | Cancelled Pre Market |
| 02305895 | MARCAINE | PFIZER CANADA ULC | Solution | BUPIVACAINE HYDROCHLORIDE 125 MG | Cancelled Post Market |
| 02311887 | MARCAINE | CARESTREAM HEALTH CANADA COMPANY | Solution | BUPIVACAINE HYDROCHLORIDE 5 MG; EPINEPHRINE BITARTRATE 0.0091 MG | Cancelled Post Market |
| 02241919 | MARCAINE | PFIZER CANADA ULC | Solution | BUPIVACAINE HYDROCHLORIDE 5 MG | Cancelled Post Market |
| 02241918 | MARCAINE | PFIZER CANADA ULC | Solution | BUPIVACAINE HYDROCHLORIDE 2.5 MG | Cancelled Post Market |
| 02018349 | MARCAINE 0.25% LIQ PRT 2.5MG/ML | SANOFI CANADA, INC. | Liquid | BUPIVACAINE HYDROCHLORIDE 2.5 MG | Cancelled Post Market |
| 01990616 | MARCAINE 0.5% AND EPINEPHRINE 1:200,000 LIQ | KODAK CANADA INC. | Liquid | BUPIVACAINE HYDROCHLORIDE 5 MG; EPINEPHRINE BITARTRATE 9.1 MCG | Cancelled Post Market |
| 02018357 | MARCAINE 0.50% LIQ BIN 5MG/ML | SANOFI CANADA, INC. | Liquid | BUPIVACAINE HYDROCHLORIDE 5 MG | Cancelled Post Market |
| 02018365 | MARCAINE 0.75% LIQ PRT 7.5MG/ML | SANOFI CANADA, INC. | Liquid | BUPIVACAINE HYDROCHLORIDE 7.5 MG | Cancelled Post Market |
| 02018373 | MARCAINE 0.75% LIQ SPINAL 7.5MG/ML | SANOFI CANADA, INC. | Liquid | BUPIVACAINE HYDROCHLORIDE 7.5 MG | Cancelled Post Market |
| 02018322 | MARCAINE E 0.25% LIQ PRT | SANOFI CANADA, INC. | Liquid | BUPIVACAINE HYDROCHLORIDE 2.5 MG; EPINEPHRINE BITARTRATE 9.1 MCG | Cancelled Post Market |
| 02018330 | MARCAINE E LIQ PRT 0.50% | SANOFI CANADA, INC. | Liquid | BUPIVACAINE HYDROCHLORIDE 5 MG; EPINEPHRINE BITARTRATE 9.1 MCG | Cancelled Post Market |
| 02241914 | MARCAINE SPINAL | PFIZER CANADA ULC | Solution | BUPIVACAINE HYDROCHLORIDE 15 MG | Dormant |
| 01976214 | SENSORCAINE FORTE | DENTSPLY CANADA LIMITED | Solution | BUPIVACAINE HYDROCHLORIDE 5 MG; EPINEPHRINE (EPINEPHRINE BITARTRATE) 5 MCG | Cancelled Post Market |
| 02305135 | VIVACAINE | SEPTODONT INC | Solution | BUPIVACAINE HYDROCHLORIDE 5 MG; EPINEPHRINE BITARTRATE 0.0091 MG | Dormant |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 31297 | 2023-07-21 | Abbreviated New Drug Submission (ANDS) | Administrative: Licensing Agreement Between Two Manufacturers |
International API supply for BUPIVACAINE HYDROCHLORIDE
7 valid EDQM Certificates of Suitability from 7 holders. 7 active FDA Drug Master Files.
Request a quote for BUPIVACAINE INJECTION BP